Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Appointments

Executives On The Move: New Responsibilities For Sanofi CMO, A Strategic Promotion At Alexion And A C-Level Resignation At Medivir

To integrate digital and medical, Sanofi’s CMO Ameet Nathwani is now also Chief Digital Officer. Alexion promotes SVP to Chief Strategy and Business Development Officer, and the CFO resigns from Swedish oncology biotech Medivir.

Appointments BioPharmaceutical

Executives On The Move: C-Suite Exits At Pfizer, Celgene And Sandoz, New President At MorphoSys

C-suite moves at cancer biotech Geron Corp, EMD Serono Inc and Kiadis Pharma, while German biotech MorphoSys AG names David Trexler as its new president.

BioPharmaceutical Appointments

Asia Executives On The Move: EdiGene, Teijin, Astellas

New round of funding allows EdiGene to hire a clinical development executive from Parexel, Teijin Pharma appoints a president, while Astellas has a new president of pharmaceutical technology.

Appointments Asia Pacific

Executives On The Move: Clinical VPs Exit Eisai And Pfizer And New Top Hire At Histogen

Clinical VPs exit Eisai and Pfizer for positions at mRNA product firm CureVac and nanomedicines developer Taiwan Liposome. New chairman and CEO takes the reins at regenerative medicine company Histogen.

Appointments BioPharmaceutical

Asia Executives On The Move: Comings And Goings At BeiGene, Harbour BioMed, TLC, GC Pharma

New Year brings a flurry of new executive moves in the life sciences sector in Asia Pacific, including the departure of BeiGene's chief commercial officer and a new chief strategy officer and CMO at Harbour Biomed.

Appointments Asia Pacific

Executives On The Move: Departures and Arrivals at Endologix, Gilead Sciences and Perrigo

Endologix CEO makes a switch to CEO at Vascular Therapies, and Clinical Research and Commercial VPs exit Gilead Sciences. Plus, producer of OTC and generic drugs Perrigo Company appoints EVP, CSO.

Appointments BioPharmaceutical

Executives On The Move: Science Leaders Exit Roche and Takeda

GI head departs Takeda for CMO spot at Ironwood Pharmaceuticals, and global head, oncology leaves Roche for CEO role at Tizona Therapeutics.

Appointments BioPharmaceutical

AZ Management Shake-Up Sees CMO Bohen Exit

Sean Bohen is to join Bahija Jallal, Mark Mallon and Ludovic Helfgott in leaving AstraZeneca as the company transitions to a new organizational structure announced last week by CEO Pascal Soriot.

Leadership Strategy

Executives On The Move: Management Changes at UroGen and Nimbus

Elizabeth Barrett becomes the new CEO and President at urology therapy firm UroGen Pharma, and Nimbus Therapeutics promotes financial exec to CFO. Meanwhile, global medical cannabis firm Tilray creates an international advisory board of business and government leaders.

Appointments BioPharmaceutical

AstraZeneca Rejig Brings Baselga On Board

A reorganization at the top of the UK firm brings with it controversial scientist Jose Baselga.

Companies Appointments

Executives On The Move: A Duo Of CFOs For Compass And Generation Bio, And At Alcon A Promotion In Japan

Cancer, inflammation and autoimmune firm Compass Therapeutics adds a new CFO, as does gene therapy company Generation Bio. And Alcon Laboratories promotes an exec to region president, Japan.

Appointments BioPharmaceutical

Executives On The Move: New Hires At EUSA Pharma And Asceneuron, Promotions At Merck And Casma Therapeutics

Bristol Myers-Squibb’s head of discovery joins Foghorn as chief scientific officer, EMD Serono’s head of neurology and immunology joins Cipher, and Merck & Co’s president of global oncology becomes its chief commercial officer.

BioPharmaceutical Appointments
See All